Home / Import refusals / AEK-9383912-2/10002/1

FDA Import Refusal AEK-9383912-2/10002/1 — Abbvie Biotechnology Gmbh

Abbvie Biotechnology Gmbh — FEI 3011277200

The FDA refused shipment AEK-9383912-2/10002/1 from Abbvie Biotechnology Gmbh (Germany) on January 22, 2026. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
January 22, 2026
Country
Germany
Product Category
Drugs and Biologics
Product Code
58SCY14 ADALIMUMAB
Charges
75

Other import refusals

  • 1FX-9795648-5/10002/1B (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9795648-5/10002/1A (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0454288-1/10002/1 (Sun May 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0362278-3/10002/1 (Sat May 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0131027-4/10002/1 (Thu Apr 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources